The validity of the social communication questionnaire in adults with intellectual disability

Brooks, Whitney T.; Benson, Betsey A.

doi:10.1016/j.rasd.2012.10.002

Cited by 36 publications

(36 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…First, findings are based on parent report data, and we did not have access to corroborating sources to validate diagnoses or medications. However, only individuals with an SCQ score at or above the recommended cutoff (≥12; Brooks and Benson 2013) were included in these analyses. It is possible that some individuals in this study would not meet full DSM-V criteria for ASD; however, previous studies suggest that parent-reported ASD diagnoses produce prevalence estimates comparable to population-based studies using validated medical records or diagnostic tools (CDC 2012(CDC , 2013Kogan et al 2008).…”

Section: Discussionmentioning

confidence: 99%

“…Of the 363 parents contacted, 113 parents completed the follow-up survey. Two of these parents had a child under the age of 12, and 11 did not have a child who met the recommended Social Communication Questionnaire (SCQ; Rutter et al 2003) research cut-off score of ≥12 (Brooks and Benson 2013). As a result, 13 parents were excluded from our analysis resulting in a final sample size of 100 participants.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Psychotropic Medication Use Among Adolescents and Young Adults with an Autism Spectrum Disorder: Parent Views About Medication Use and Healthcare Services

Lake

Vogan²,

Sawyer³

et al. 2015

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

Objectives: Psychotropic medications are frequently used to treat mental health and behavioral issues in adolescents and adults with an autism spectrum disorder (ASD).Although parents of individuals with ASD frequently take on medication management for their child, there is limited literature on parent perspectives of their child's medication use or their views about the health care services they receive, particularly in adulthood.The current study examined and compared parents of adolescents and of young adults with ASD on their child's psychotropic medication use and their views about health care services. Methods: One hundred parents of adolescents and young adults with ASD (ages 12-30 years) completed an online survey about their experience with their child's health care services and medication use. Results: Parents of young adults were less likely to use non-pharmacological services before using a psychotropic medication compared to parents of adolescents. Parents of young adults were also less likely to believe their prescribing health care provider had adequate expertise in ASD and were less satisfied with how their prescriber monitored their child's medication use. Conclusion: Findings highlight the need to build capacity among health care providers supporting individuals with ASD as they transition into adulthood. There is also a need for improved medication monitoring and increased awareness of the different mental health challenges individuals with ASD encounter as they age. We know even less about parent perspectives as individuals with ASD enter adulthood, when the needs of patients and families may change (Graetz 2010). This transition can be particularly challenging for individuals with ASD, not only in terms of physiological changes, but also because of possible changes to residence, education, and employment. Additionally, young adults may encounter significant changes in service eligibility or accessibility, and some adults may no longer be eligible or have access to funded non-pharmacological services or supports. For example, adolescents access services through children's services and the school system, whereas young adults receive services within the adult system. Further, young adults must move from the pediatric to the adult health care system, where access to health care professionals and trainees who have the capacity and expertise to care for individuals with ASD is sparse (Bruder et al. 2012;Cheak-Zamora et al. 2013;Marrus et al. 2014). Lastly, medication efficacy, tolerability, and the reason(s) for prescribing medication or the individual's psychiatric presentation, may also differ between the two groups. For these reasons, there is a clear need to better understand the unique experience of medication use among transitioning youth with ASD, and how these experiences differ from younger adolescents.In the only study to examine parent perspectives on psychotropic medication use among adolescents and adults with ASD, we identified a number of key concerns related to medication u...

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Psychotropic Medication Use Among Adolescents and Young Adults with an Autism Spectrum Disorder: Parent Views About Medication Use and Healthcare Services

Lake

Vogan²,

Sawyer³

et al. 2015

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…However, subsequent validity studies did not confirm such psychometric properties of the SCQ when applied to different populations (e.g., individuals with intellectual disabilities, individuals with Down syndrome). At the cut-off of 15, most of these studies reported lower (< 0.80) and unsatisfactory balance of sensitivities and specificities (e.g., Allen, Silove, Williams, and Hutchins 2007;Brooks and Benson 2013;Eaves, Wingert, Ho, and Mickelson 2006;Oosterling et al 2010;Snow and Lecavalier 2008;Wiggins, Bakeman, Adamson, and Robins 2007;Witwer and Lecavalier 2007), and quite a few of them suggested lowering the cut-off for improving the discriminant utility of the SCQ (e.g., Corsello et al 2007;Johnson et al 2011;Lee, David, Rusyniak, Landa, and Newschaffer 2007;Schanding, Nowell, and Goin-Kochel 2012;Wiggins et al 2007). Therefore, the unpredictable nature of the SCQ has caused some researchers and clinicians to question its validity.…”

mentioning

confidence: 99%

“…Additionally, it is not always clear when researchers should utilize the Current version over the Lifetime version or if either provides more reliable results. While the SCQ Current was designed to measure change over time for assessing the effectiveness of therapeutic or educational interventions (Rutter et al 2003a, b), many actually rely on it for children under 5 years old (see Brooks and Benson 2013;Corsello et al 2007;Lee et al 2007). The few studies which explicitly evaluated the SCQ Current version (Corsello et al 2007;Oosterling et al 2010) found particularly lower specificities of it among very young (approximately 2 to 4 years old) children.…”

mentioning

confidence: 99%

Psychometric Analysis of the Social Communication Questionnaire Using an Item-Response Theory Framework: Implications for the Use of the Lifetime and Current Forms

Wei

Chesnut

Barnard‐Brak

et al. 2014

J Psychopathol Behav Assess

View full text Add to dashboard Cite

The Social Communication Questionnaire (SCQ) was developed as a screener of Autism Spectrum Disorder (ASD). To date, the majority of the SCQ utility studies focused on its external validity (e.g., ROC curve analyses), but very few have addressed the internal validity issues. With samples consisting of 2,134 individuals available from the National Database for Autism Research (NDAR), the current study examined the factor structure, item-level characteristics, and measurement equivalence of the SCQ forms (i.e., Lifetime form and Current form) using both the classical true score theory and the Item Response Theory (IRT). While our findings indicate sufficient psychometric properties of the SCQ Lifetime form, measurement issues emerged with respect to the SCQ Current form. These issues include lower internal consistencies, a weaker factor structure, lower item discriminations, significant pseudo-guessing effects, and subscale-level measurement bias. Thus, we caution researchers and clinicians about the use of the SCQ Current form. In particular, it seems inappropriate to use the Current form as an alternative to the Lifetime form among children younger than 5 years old or under other special situations (e.g., teacher-report data), although such practices were advised by the publisher of the SCQ. Instead, we recommend modifying the wording of the Lifetime form items rather than switching to the Current form where a 3-month timeframe is specified for responding to SCQ items. Future studies may consider investigating the association between the temporality of certain behaviors and the individual's potential for being diagnosed with ASD, as well as the age neutrality of the SCQ.

show abstract

“…Thus, there is a high probability of missing possible ASD cases if employing only the diagnosed cases in surveying early childhood morbidity. In addition, comprehensive diagnostic assessment is often expensive and time-consuming work completed by a multidisciplinary team of professionals [21], and this can be stressful for children being assessed as well as their parents. Screening method improvements could thusly decrease the specific problem of diagnostic bias due to gaps in socioeconomic status or access to medical services [22] [23].…”

Section: Introductionmentioning

confidence: 99%

The Association of Autism Spectrum Disorders and Symptoms of Asthma, Allergic Rhinoconjunctivitis and Eczema among Japanese Children Aged 3 - 6 Years

Hori¹,

Tsujiguchi²,

Kambayashi³

et al. 2017

Health

View full text Add to dashboard Cite

There is insufficient epidemiological evidence on the relationship between autism spectrum disorder (ASD) and allergic diseases. We performed a cross-sectional survey to elucidate the associations between them using validated screening tools. The participants were children aged 3 -6 years attending kindergarten or nursery school in Shika Town, Japan (n = 417; valid response rate = 80.4%). Autism spectrum features were scored on the Social Communication Questionnaire (SCQ). Allergic symptoms (asthma, allergic rhinoconjunctivitis, and eczema) were determined according to the criteria of the International Study of Asthma and Allergies in Childhood. A total of 15 children (4.5%) had an SCQ score of 11 points or higher. The prevalence of symptoms was 14.7% for asthma, and 5.3% for allergic rhinoconjunctivitis, and 11.4% for eczema. Logistic regression indicated that symptoms of eczema were significantly associated with SCQ scores of 11 points or higher [odds ratio (OR), 4.38; 95% confidence interval (CI), 1.41 -13.59]. The association persisted after adjustment for age, sex, and BMI (OR, 3.84; 95% CI, 1.20 -12.24). Moreover, asthmatic symptoms were significantly associated with male sex (OR, 2.09; 95% CI, 1.12 -3.92) and overweight status (OR, 2.45; 95% CI, 1. 03 -5.83). This suggests that higher SCQ scores, which imply more autism spectrum features, are associated with higher prevalence of eczema symptoms. While no causal relationships can be made, ASD might be associated with How to cite this paper:

show abstract

The validity of the social communication questionnaire in adults with intellectual disability

Cited by 36 publications

References 33 publications

Psychotropic Medication Use Among Adolescents and Young Adults with an Autism Spectrum Disorder: Parent Views About Medication Use and Healthcare Services

Psychotropic Medication Use Among Adolescents and Young Adults with an Autism Spectrum Disorder: Parent Views About Medication Use and Healthcare Services

Psychometric Analysis of the Social Communication Questionnaire Using an Item-Response Theory Framework: Implications for the Use of the Lifetime and Current Forms

The Association of Autism Spectrum Disorders and Symptoms of Asthma, Allergic Rhinoconjunctivitis and Eczema among Japanese Children Aged 3 - 6 Years

Contact Info

Product

Resources

About